Cellectis Inc.

Welcome to Selectus' fourth quarter and full year 2020 earnings call. At this time, all participants are in a listen-only mode. In question and answer session, we'll follow the formal presentation. If anyone should require operator assistance during today's conference, please press star zero from your telephone keypad. Please note, this conference is being recorded. At this time, I'll turn the conference over to Simon Harness, Chief Investment Officer. Simon, you may begin.

Thank you and welcome everyone to Selecta's fourth quarter and full year corporate update and financial results conference call for the 2020 fiscal year. Joining me on the call today with prepared remarks are Dr. Andre Choulika, our Chief Executive Officer, Dr. Carrie Brownstein, our Chief Medical Officer, and Eric Dutton, our Chief Financial Officer. Yesterday evening, Selectus filed its annual report and issued a press release reporting our financial results for the fourth quarter and year ending December 31, 2020. These reports and press releases are available on our website at selectus.com. As a reminder, we will make forward-looking statements regarding Selectus Financial Outlook in addition to its regulatory and product development plans. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be found in our most recent form 20F filed with the SEC and the financial report, including the management report for the year ending on December 31st, 2020 and subsequent filing selectives makes with the SEC from time to time.

I would now like to turn the call over to Andre.